The assay that we are referring to is called DRUGMATRIX and it specifically focuses on measuring dopamine D2L radioligand binding. The ligand that is attached to this binding is [3H] Spiperone. One important aspect of this assay is that it has a homologous single protein target assigned, which ensures consistent and accurate results. The assay is conducted using CHO cells, with the membrane being the subcellular fraction that is tested. It is important to note that this assay is an in vitro test, where the focus is on measuring the binding of the ligand. Therefore, the assay type's description is binding. Does this molecule show effectiveness in this assay?